I-Mab Biopharma Revenue

Biotechnology Research • Rockville, Maryland, United States • 101-200 Employees

I-Mab Biopharma revenue & valuation

Annual revenue	$3,899,131
Revenue per employee	$34,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$12,500,000
Total funding	$483,000,000

Key Contact at I-Mab Biopharma

Xi-Yong Mba

CEO & Board Member

Mobile @i-mabbiopharma.com

Company overview

Headquarters	2440 Research Blvd, Suite 400, Rockville, Maryland 20850, US
Phone number	+862160578000
Website	i-mabbiopharma.com
SIC	873
Keywords	Biopharmaceutical, Cancer, Drug Development, Antibody, Biologics, Immuno-Oncology, Monoclonal Antibodies, Bispecific Antibodies
Founded	2016
Employees	101-200
Socials

I-Mab Biopharma Email Formats

I-Mab Biopharma uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@i-mabbiopharma.com), used 75% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@i-mabbiopharma.com	75%
{first name}.{last name}	john.doe@i-mabbiopharma.com	25%

About I-Mab Biopharma

I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. The Company’s differentiated pipeline is led by givastomig, a potential best-in-class, bispecific antibody (Claudin 18.2 x 4-1BB) designed to treat Claudin 18.2-positive gastric cancers. Givastomig conditionally activates T cells via the 4-1BB signaling pathway in the tumor microenvironment where Claudin 18.2 is expressed. Givastomig is being developed for first-line metastatic gastric cancers, with additional potential in other solid tumors. In Phase 1 trials, givastomig was observed to maintain strong tumor-binding and anti-tumor activity, attributable to a potential synergistic effect of proximal interaction with Claudin 18.2 and 4-1BB, while minimizing toxicities commonly seen with other 4-1BB agents.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Director

Manager

Entry

Employees by Department

I-Mab Biopharma has 43 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore I-Mab Biopharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-10-04	14	$418,000,000
2025-09-01	14	$65,000,000

Funding Insights

$483,000,000

Total funding amount

$65,000,000

Most recent funding amount

Number of funding rounds

I-Mab Biopharma Tech Stack

Discover the technologies and tools that power I-Mab Biopharma's digital infrastructure, from frameworks to analytics platforms.

Twitter Emoji

Font scripts

Baidu Analytics

Analytics

jQuery

JavaScript libraries

Nginx

Reverse proxies

Contact Form 7

Form builders

PHP

Programming languages

SiteOrigin Page Builder

Page builders

WordPress

Blogs

Swiper

JavaScript libraries

Bootstrap

UI frameworks

MySQL

Databases

Polylang

Translation

Frequently asked questions

I-Mab Biopharma is located in Rockville, Maryland, US.

You can reach I-Mab Biopharma at +862160578000.

I-Mab Biopharma generates an estimated annual revenue of $3,899,131. This revenue figure reflects the company's market position and business performance in its industry.

I-Mab Biopharma has an estimated valuation of $12,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

I-Mab Biopharma was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

I-Mab Biopharma has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

I-Mab Biopharma has raised a total of $483,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at I-Mab Biopharma

Xi-Yong Mba

CEO & Board Member

Mobile @i-mabbiopharma.com

4.8

40,000 users